ASKA Pharmaceutical Co., Ltd. Announces Dividend for the Year Ended March 31, 2020, Payable on June 26, 2020; Provides Dividend Guidance for the Second Quarter and Year Ended March 31, 2021; Reports Consolidated Earnings Results for the Year Ended March 31, 2020; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021
May 12, 2020 at 04:24 pm EDT
Share
ASKA Pharmaceutical Co., Ltd. announced dividend for the year ended March 31, 2020. For the year, the company announced dividend of JPY 10.00 per share compared to JPY 7.00 a year ago. Scheduled date to commence dividend payments is June 26, 2020.
The company provided dividend guidance for the second quarter and year ended March 31, 2021. For the second quarter, The company expects dividend of JPY 7.00 per share compared to JPY 7.00 per share a year ago.
For the year, The company expects dividend of JPY 7.00 per share compared to JPY 10.00 per share a year ago.
The company reported consolidated earnings results for the year ended March 31, 2020. For the year, the company reported net sales of JPY 52,542 million against JPY 46,706 million a year ago. Operating profit was JPY 1,507 million against JPY 1,782 million a year ago. Profit attributable to owners of parent was JPY 649 million against JPY 1,744 million a year ago. Earnings per share was JPY 22.96 compared to JPY 61.81 a year ago.
The company provided consolidated earnings guidance for the year ending March 31, 2021. For the year, the company expects net sales of JPY 53,000 million, operating income of JPY 2,000 million, and profit attributable to owners of parent of JPY 1,500 million. Earnings per share was JPY 52.95.
ASKA Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.
ASKA Pharmaceutical Co., Ltd. Announces Dividend for the Year Ended March 31, 2020, Payable on June 26, 2020; Provides Dividend Guidance for the Second Quarter and Year Ended March 31, 2021; Reports Consolidated Earnings Results for the Year Ended March 31, 2020; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2021
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. 
